Track Record

○ Supporting global clients to launch 29 innovative drugs (to date)

○ Developing 200+ CDMO projects annually, including CMC, and Phase I to III projects

○ Delivering 500+ tons brand name APIs annually to top MNC Pharma clients and Biotech clients

○ Supplying API for 4 blockbuster drugs for top MNC pharma clients with 98%+ on-time delivery in full (OTIF)

○ Providing multi-Kg scale commercial API from Brevard NC cGMP Facility annually

Unique Expertise in Drug Development

Raybow stands at the forefront of small molecule drug development with a team of 800+ chemists, 50%+ with PhD and MSc degrees. Our leading in-house technology platforms include:

○ Chiral ligands for asymmetric transformations

○ Fluorination

○ Flow Chemistry

○ Peptides and conjugates

○ Solid-state and Separation

Efficient and Cost-Competitive Service

An experience project management team uses flexible capacity to efficiently manage projects from CMC to full-scale commercialization. Multiple sites in the US and China, equipped with state-of-the-art instruments and equipment, ensure high-quality, efficient and cost competitive delivery.

Excellence in HSEQ

○ Repeatedly passed worldwide regulatory authority inspections (FDA, Europe, Japan, China, Brazil, Mexico)

○ ISO14000/OHSAS18000 certified

○ Repeatedly passed strict EHS audits from multinational pharma companies

○ Continuous commitment to top EHS performance systems

We are dedicated to your success, every step of the way.